Table 2 Demographics of PDAC disease monitoring cohort including both CA19-9-elevated and non-elevated patients.

From: Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma

Demographics

PDAC (Stage IV)

CA19-9 elevated

CA19-9 non-elevated

N

16

10

Age (Y)

<60

5

6

≥60

11

4

Gender

Male

12

10

Female

4

0

Back to article page